The Latest Breaking News from Pfizer

Cost of private Covid jabs risks widening health inequalities, experts warn

Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

The Guardian - UK · Mar 28, 2024

Boots to offer Covid vaccines in England for nearly £100 a jab

Pharmacy to offer Pfizer/BioNTech vaccine to those not eligible for NHS booster shot from next week

The Guardian - UK · Mar 26, 2024

In a pandemic milestone, the NIH ends guidance on COVID treatment

The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.

WEKU · Mar 19, 2024

U.S. must stop syphilis killing babies

The government isn’t doing much to prevent shortages of the only drug that treats syphilis during pregnancy

Salon · Mar 6, 2024

Should You Buy These 2 Dividend Stocks Yielding More Than 5% Right Now?

There are other reasons to consider buying a dividend stock besides the high yield. Here's a closer look at two stocks that offer yields over 5% right now.

Barchart · Mar 5, 2024

2 Cheap Dividend Stocks to Buy This March and Hold for the Long Term

While the S&P 500 Index's dividend yield is just about half of its long-term averages, Ford and Pfizer are two dividend-paying stocks that offer healthy yields. Plus, their cheap valuations mean that there is a reasonable probability of upside over the next couple of years.

Barchart · Mar 1, 2024

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times · Feb 27, 2024

Surge in syphilis cases drives some doctors to ration penicillin

The drug is the go-to treatment for syphilis and the only one recommended for pregnant people. But a shortage of the injectable drug has prompted some public health agencies to ration it.

WEKU · Feb 26, 2024

A Better Way To Fight Future Pandemics

Four years after the emergence of Covid-19, the conversation in global public health has moved on from dealing with an immediate crisis to how we can best prepare for the next pandemic.

International Business Times · Feb 23, 2024

Large COVID-19 vaccine study finds risks

Any pharmaceutical has risk of side effects, but a COVID infection is far more dangerous than the vaccines

Salon · Feb 23, 2024